ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 602613 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 602613; 2) Community: the network communities that were significantly associated with the response to NSC 602613; 3) Molecule: the relationships between components within communities and NSC 602613; 4) MDR: the compounds that were significantly associated with the NSC 602613.

NSC Compound Enrichment Correlation
NSC 752461 Null 0.0382675857669585 0.46184864
NSC 753218 3-hydroxy-5,6-dihydro-6-imino-9-methoxyisoindolo-[2,1-a]quinoxaline 0.0382675857669585 0.30264017
NSC 755423 Null 0.0382675857669585 0.42445364
NSC 75890 1,9-Pyrazoloanthrone 0.0382675857669585 -0.1898962
NSC 94037 Mikanolide 0.0382675857669585 0.30955767
NSC 114382 Null 0.0382675857669588 0.55214009
NSC 207895 Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide 0.0382675857669588 0.41450209
NSC 274548 Gold, [.mu.-[[5,5'-methylenebis[1H-tetrazolato]](2-)-N(1):N(1')]]bis(triphenylphosphine)di- 0.0382675857669588 0.53148782
NSC 327182 L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]benzoyl]- 0.0382675857669588 0.22719862
NSC 371488 9-(3,4-dichlorophenyl)-2,7-bis((dimethylamino)methyl)-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2H)-dione, dihydrochloride 0.0382675857669588 0.23587281
Total:106  Current:85    [First] [Prev] [Next] [Last]